Novel EUCAST-approved quality control range for Escherichia coli ATCC® 25922 and cefoperazone 30 µg discs

Journal of Antimicrobial Chemotherapy · Published 2026-06-03 · DOI 10.1093/jac/dkag207

Authors (15)

Johanna Jahnen, Erika Matuschek, Leonard Limpinsel, Heike Kaspar, Julia M Riehm, Paul Siller, Ricarda Daher, Svenja Sander, Thomas Heberer, Sarah Bolda, Maria Kluge, Gunnar Kahlmeter, John Turnidge, Stefan Schwarz, Andrea T Feßler

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jahnen, J., Matuschek, E., Limpinsel, L., et al. (2026). Novel EUCAST-approved quality control range for Escherichia coli ATCC® 25922 and cefoperazone 30 µg discs. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag207

Related articles

• Antifungal susceptibility profiles of clinical and environmental Scedosporium and Lomentospora isolates from Taiwan: focus on olorofim activity and phylogenetic heterogeneity · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018–23 · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Paediatric outpatient antibiotic utilization patterns and use of healthcare services before, during and after the COVID-19 pandemic: interrupted time series analysis using data from Norway and Japan · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Quinolones and risk of haemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a nationwide retrospective active-comparator cohort study · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Predictive performance of an antibiotic precision dosing software program in critically ill adults with infection · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing Enterobacterales · Journal of Antimicrobial Chemotherapy · 2026 · Same journal